Company Directory > CRO > Perceptive
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Perceptive and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR

Perceptive

London, United Kingdom
VISIT WEBSITE
Perceptive is a leading global technology-enabled service provider for preclinical and clinical trial imaging, eClinical services, and discovery solutions. The company supports pharmaceutical, biotech, and clinical research organizations by providing end-to-end services from protocol design and site training to image collection, analysis, and regulatory-ready data management. Formed through the consolidation of specialist businesses—including the acquisition of Invicro and the former Calyx eClinical business—Perceptive operates across three integrated divisions: Perceptive Discovery, Perceptive eClinical, and Perceptive Imaging. With over 50 years of combined experience, the company has supported more than 11,000 clinical trial implementations and over 800 regulatory approvals.
CLASSIFICATION
Company Type:CRO
Industry:CRO
Sub-Industry:Clinical Imaging, eClinical Services, Preclinical Discovery
SIZE & FINANCIALS
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Radiopharmaceuticals, Cell & Gene Therapy
Active Trials:0
Trial Phases:-
FDA Approvals:800
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Invicro, Calyx (former)
Key Partnerships:Certis Oncology (Translational Radiopharmaceutical development)
COMPETITION
Position:Leader
Competitors:ICON Plc, Parexel, IQVIA, PPD (Thermo Fisher)
LEADERSHIP
Key Executives:
Mario Papillon - CEO, Perceptive eClinical
Doug Fulling - CEO, Perceptive Imaging
Gregory Goldmacher - Chief Scientific & Medical Officer
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Perceptive. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.